Radiological findings :peritoneal carcinomatosis
Sharing a poster presentation done in Medcon2019 by Harika B 1styear PG& DR.ANV Prasad, Associate Professor NRI Institute of Medical Sciences CT Findings: Severe ascites seen. Multiple small enhancing nodules seen in the parietal peritoneum, visceral peritoneum and omentum with predominant pelvic distribution.Heterogeneously enhancing lesion of 3x2.1x1.8cm seen in RIF. Appendix is not seen separately from the lesion. Final Impression of Peritoneal carcinomatosis (pseudomyxoma peritoni) - likely due to mucinous adeno Ca. appendix.Peritoneal carcinomatosis(PC) is the term given to malignant tumour seeding of the peritoneum with most common primaries being1. Ovarian (71%)2. Gastric (17%)3. Colorectal (10%) cancers.-- Distribution of disease in PC is related to peritoneal ﬂuid circulation along predetermined anatomical routesThe most common seeding sites includeØ Pouch of DouglasØ Distal small-bowel mesentery near the ileocaecal junction,Ø Sigmoid mesocolonØ Right paracolic gutterØ Pouch of MorisonØ Right subdiaphragmatic areaFamous Radiology Blog http://www.sumerdoc.blogspot.com TeleRad Providers at www.teleradproviders.com Mail us at firstname.lastname@example.org
Conditions: Lung Cancer; Non Small Cell Lung Cancer Intervention: Sponsors: Picomole Inc; University of California, Irvine Not yet recruiting
Conditions: Digestive System Neoplasms; Thoracic Neoplasms Interventions: Behavioral: Emotional skills; Behavioral: Short free talk and relaxation Sponsors: University Hospital, Lille; SCALab UMR CNRS 9193 Not yet recruiting
Conditions: Breast Cancer Metastatic; BRCA 1 Gene Mutation; BRCA 2 Gene Mutation Intervention: Drug: SC10914 Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. Recruiting
Condition: MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer Intervention: Drug: AK104 Sponsor: Peking University Not yet recruiting
Conditions: Ovarian Neoplasms; Fallopian Tube Neoplasms; Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female; Endocrine System Diseases; Gonadal Disorders; Carcinoma; Bevaci...
Condition: Metastatic Prostate Cancer Interventions: Behavioral: Exercise therapy + radiation therapy; Radiation: Radiation therapy Sponsor: Milton S. Hershey Medical Center Not yet recruiting
Condition: Breast Cancer Interventions: Behavioral: Postcard; Behavioral: Small Gift; Behavioral: Loss Frame and Fear Appeals Sponsor: Geisinger Clinic Not yet recruiting
Conditions: Head and Neck Squamous Cell Carcinoma; Malignant Solid Neoplasm Interventions: Drug: Alisertib; Biological: Pembrolizumab Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
Condition: Prostate Cancer Interventions: Diagnostic Test: PSMA PET/CT guided intensification of therapy; Other: Control Arm Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Cancer Society Research Institute (CCSRI); Lantheus Medical Imaging; British Columbia Cancer Agency; London Health Sciences Centre; Princess Margaret Hospital, Canada; Tom Baker Cancer Centre; Mc Master University; Institute of Healt...
Authors: Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T Abstract Objective: The purpose of the present review was to provide evidence-based guidance about the provision of cytoreductive surgery (crs) with hyperthermic intraperitoneal chemotherapy (hipec) in the treatment of peritoneal cancers. Methods: The guideline was developed by the Program in Evidence-Based Care together with the Surgical Oncology Program at Ontario Health (Cancer Care Ontario) through a systematic review of relevant literature, patient- and caregiver-specific consultation, and internal and external reviews. Results: Re...